NK cell self tolerance, responsiveness and missing self recognition

Seminars in Immunology

Volumn 26, Issue 2, 2014, Pages 138-144

  Shifrin, Nataliya ^a   Raulet, David H ^a   Ardolino, Michele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Missing self; NK cell education

Indexed keywords

ANTIGEN RECOGNITION; CELL POPULATION; CROSS LINKING; ENVIRONMENTAL CHANGE; HEMATOPOIETIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; INFLAMMATION; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PLASTICITY; REVIEW; STEADY STATE; TUMOR CELL; VIRUS; ANIMAL; CYTOLOGY; CYTOTOXICITY; IMMUNOLOGY; METABOLISM;

HISTOCOMPATIBILITY ANTIGEN;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS; HUMANS; KILLER CELLS, NATURAL; SELF TOLERANCE;

EID: 84897958476     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.02.007     Document Type: Review

References (89)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
2. Herberman R.B., Nunn M.E., Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975, 16:216-229.
3. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975, 5:112-117.
4. Glas R., Franksson L., Une C., Eloranta M.L., Ohlen C., Orn A., et al. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype: an adaptive component of NK cell-mediated responses. J Exp Med 2000, 191:129-138.
5. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001, 413:165-171.
6. Fehniger T.A., Cai S.F., Cao X., Bredemeyer A.J., Presti R.M., French A.R., et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 2007, 26:798-811.
7. Henkart P. Mechanism of lymphocyte-dedicated cytotoxicity. Annu Rev Immunol 1985, 3:31-58.
8. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002, 20:323-370.
9. Zamai L., Ahmad M., Bennett I.M., Azzoni L., Alnemri E.S., Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998, 188:2375-2380.
10. Kayagaki N., Yamaguchi N., Nakayama M., Takeda K., Akiba H., Tsutsui H., et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 1999, 163:1906-1913.
11. Diefenbach A., Raulet D.H. Strategies for target cell recognition by natural killer cells. Immunol Rev 2001, 181:170-184.
12. Lanier L.L. NK cell receptors. Annu Rev Immunol 1998, 16:359-393.
13. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001, 19:197-223.
14. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003, 3:781-790.
15. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
16. Raulet D.H., Gasser S., Gowen B.G., Deng W., Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 2013, 31:413-441.
17. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002, 17:19-29.
18. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010, 235:267-285.
19. Schleinitz N., Vely F., Harle J.R., Vivier E. Natural killer cells in human autoimmune diseases. Immunology 2010, 131:451-458.
20. Guerra N., Pestal K., Juarez T., Beck J., Tkach K., Wang L., et al. A selective role of NKG2D in inflammatory and autoimmune diseases. Clin Immunol 2013, 149:432-439.
21. Shibuya K., Lanier L.L., Phillips J.H., Ochs H.D., Shimizu K., Nakayama E., et al. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999, 11:615-623.
22. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
23. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002, 99:8826-8831.
24. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001, 28:42-45.
25. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 2001, 194:29-44.
26. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001, 2:951-956.
27. Perussia B., Tutt M.M., Qiu W.Q., Kuziel W.A., Tucker P.W., Trinchieri G., et al. Murine natural killer cells express functional Fc gamma receptor II encoded by the Fc gamma R alpha gene. J Exp Med 1989, 170:73-86.
28. Brown M.H., Boles K., van der Merwe P.A., Kumar V., Mathew P.A., Barclay A.N. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998, 188:2083-2090.
29. Dong Z., Cruz-Munoz M.E., Zhong M.C., Chen R., Latour S., Veillette A. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol 2009, 10:973-980.
30. Yokoyama W.M., Seaman W.E. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993, 11:613-635.
31. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996, 14:619-648.
32. Raulet D.H., Held W., Correa I., Dorfman J., Wu M.-F., Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997, 155:41-52.
33. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799.
34. b. J Exp Med 1998, 188:1841-1848.
35. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998, 95:5199-5204.
36. Burshtyn D., Scharenberg A., Wagtmann N., Rajagopalan S., Peruzzi M., Kinet J.-P., et al. Recruitment of tyrosine phosphatase HCP by the NK cell inhibitory receptor. Immunity 1996, 4:77-85.
37. Olcese L., Lang P., Vely F., Cambiaggi A., Marguet D., Blery M., et al. Human and mouse killer-cell inhibitory receptors recruit Ptp1c and Ptp1d protein tyrosine phosphatases. J Immunol 1996, 156:4531-4534.
38. Campbell K.S., Dessing M., Lopez-Botet M., Cella M., Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 1996, 184:93-100.
39. Binstadt B.A., Brumbaugh K.M., Dick C.J., Scharenberg A.M., Williams B.L., Colonna M., et al. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996, 5:629-638.
40. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005, 105:4416-4423.
41. Hanke T., Takizawa H., McMahon C.W., Busch D.H., Pamer E.G., Miller J.D., et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 1999, 11:67-77.
42. Joncker N.T., Fernandez N.C., Treiner E., Vivier E., Raulet D.H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol 2009, 182:4572-4580.
43. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
44. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
45. Joncker N.T., Raulet D.H. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol Rev 2008, 224:85-97.
46. Brodin P., Karre K., Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 2009, 30:143-149.
47. Fauriat C., Ivarsson M.A., Ljunggren H.G., Malmberg K.J., Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 2009, 115:1166-1174.
48. Beziat V., Traherne J.A., Liu L.L., Jayaraman J., Enqvist M., Larsson S., et al. Influence of KIR gene copy number on natural killer cell education. Blood 2013, 121:4703-4707.
49. Yu J., Heller G., Chewning J., Kim S., Yokoyama W.M., Hsu K.C. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 2007, 179:5977-5989.
50. Brodin P., Lakshmikanth T., Johansson S., Karre K., Hoglund P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2009, 113:2434-2441.
51. Andrews D.M., Sullivan L.C., Baschuk N., Chan C.J., Berry R., Cotterell C.L., et al. Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat Immunol 2012, 13:1171-1177.
52. Raulet D.H., Vance R.E. Self-tolerance of natural killer cells. Nat Rev Immunol 2006, 6:520-531.
53. Jonsson A.H., Yokoyama W.M. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 2009, 101:27-79.
54. Joncker N.T., Shifrin N., Delebecque F., Raulet D.H. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med 2010, 207:2065-2072.
55. Doucey M.A., Scarpellino L., Zimmer J., Guillaume P., Luescher I.F., Bron C., et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol 2004, 5:328-336.
56. Scarpellino L., Oeschger F., Guillaume P., Coudert J.D., Levy F., Leclercq G., et al. Interactions of Ly49 family receptors with MHC Class I ligands in trans and cis. J Immunol 2007, 178:1277-1284.
57. Chalifour A., Scarpellino L., Back J., Brodin P., Devevre E., Gros F., et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009, 30:337-347.
58. Bessoles S., Angelov G.S., Back J., Leclercq G., Vivier E., Held W. Education of murine NK cells requires both cis and trans recognition of MHC class I molecules. J Immunol 2013, 191:5044-5051.
59. Zafirova B., Mandaric S., Antulov R., Krmpotic A., Jonsson H., Yokoyama W.M., et al. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 2009, 31:270-282.
60. Sheppard S., Triulzi C., Ardolino M., Serna D., Zhang L., Raulet D.H., et al. Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood 2013, 121:5025-5033.
61. Walzer T., Blery M., Chaix J., Fuseri N., Chasson L., Robbins S.H., et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA 2007, 104:3384-3389.
62. Narni-Mancinelli E., Jaeger B.N., Bernat C., Fenis A., Kung S., De Gassart A., et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 2012, 335:344-348.
63. Oppenheim D.E., Roberts S.J., Clarke S.L., Filler R., Lewis J.M., Tigelaar R.E., et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005, 6:928-937.
64. Champsaur M., Beilke J.N., Ogasawara K., Koszinowski U.H., Jonjic S., Lanier L.L. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J Immunol 2010, 185:157-162.
65. Sun J.C., Lanier L.L. Tolerance of NK cells encountering their viral ligand during development. J Exp Med 2008, 205:1819-1828.
66. Moretta L., Ferlazzo G., Bottino C., Vitale M., Pende D., Mingari M.C., et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006, 214:219-228.
67. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999, 5:405-411.
68. Mortier E., Advincula R., Kim L., Chmura S., Barrera J., Reizis B., et al. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets. Immunity 2009, 31:811-822.
69. Jaeger B.N., Donadieu J., Cognet C., Bernat C., Ordonez-Rueda D., Barlogis V., et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med 2012, 209:565-580.
70. Ebihara T., Jonsson A.H., Yokoyama W.M. Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci USA 2013, 110:E4232-E4237.
71. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000, 191:771-780.
72. Koka R., Burkett P.R., Chien M., Chai S., Chan F., Lodolce J.P., et al. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med 2003, 197:977-984.
73. Lodolce J.P., Burkett P.R., Boone D.L., Chien M., Ma A. T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J Exp Med 2001, 194:1187-1194.
74. Castillo E.F., Schluns K.S. Regulating the immune system via IL-15 transpresentation. Cytokine 2012, 59:479-490.
75. Mortier E., Woo T., Advincula R., Gozalo S., Ma A. IL-15R{alpha} chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med 2008, 205:1213-1225.
76. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995, 14:3654-3663.
77. Caraux A., Lu Q., Fernandez N., Riou S., Di Santo J.P., Raulet D.H., et al. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat Immunol 2006, 7:747-754.
78. Roth C., Rothlin C., Riou S., Raulet D.H., Lemke G. Stromal-cell regulation of natural killer cell differentiation. J Mol Med 2007, 85:1047-1056.
79. Lemke G. Biology of the TAM receptors. Cold Spring Harb Perspect Biol 2013, 5:a009076.
80. Elliott J.M., Wahle J.A., Yokoyama W.M. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med 2010, 207:2073-2079.
81. Salcedo M., Andersson M., Lemieux S., Van Kaer L., Chambers B.J., Ljunggren H.G. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur J Immunol 1998, 28:1315-1321.
82. Sun J.C., Lanier L.L. Cutting edge: viral infection breaks NK cell tolerance to "missing self". J Immunol 2008, 181:7453-7457.
83. Orr M.T., Murphy W.J., Lanier L.L. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 2010, 11:321-327.
84. Vahlne G., Lindholm K., Meier A., Wickstrom S., Lakshmikanth T., Brennan F., et al. In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2. Eur J Immunol 2010, 40:813-823.
85. Kusunoki Y., Kyoizumi S., Honma M., Kubo Y., Ohnishi H., Hayashi T., et al. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules. J Immunol 2000, 165:3555-3563.
86. Garrido F., Algarra I. MHC antigens and tumor escape from immune surveillance. Adv Cancer Res 2001, 83:117-158.
87. Romagne F., Andre P., Spee P., Zahn S., Anfossi N., Gauthier L., et al. Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood 2009, 114:2667-2677.
88. Vey N., Bourhis J.H., Boissel N., Bordessoule D., Prebet T., Charbonnier A., et al. A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission. Blood 2012, 120:4317-4323.
89. Benson D.M., Hofmeister C.C., Padmanabhan S., Suvannasankha A., Jagannath S., Abonour R., et al. A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma. Blood 2012, 120:4324-4333.